Takayasu Arteritis (TAK)

Cardiovascular·MeSH: Takayasu Arteritis

Prevalence

0.5 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Takayasu Arteritis (TAK)?

There are 1 clinical trial targeting Takayasu Arteritis (TAK) tracked by BioSniper.

What is the prevalence of Takayasu Arteritis (TAK)?

The estimated prevalence of Takayasu Arteritis (TAK) is approximately 0.5 per 100,000 population.

Deep-dive into Takayasu Arteritis (TAK)

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Takayasu Arteritis (TAK) — Drugs in Development & Clinical Trials | BioSniper